A T Lely - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

A T Lely

Showing results (21-30 of 22) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 22 results.

European Journal of Preventive Cardiology|May 19, 2021

Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectivenessSteven H J Hageman, Jannick A N Dorresteijn, Michiel L Bots, et al.

The American Journal of Medicine|February 15, 2026

Implications of 2023 ACR/EULAR Classification Criteria for antiphospholipid syndrome and current diagnostic and therapeutic insights: a Delphi consensusDrs B C Geertsema-Hoeve, Dr M C Stam-Slob, Dr M Bijl, et al.

Pageof 3

Search research articles

Showing results (21-30 of 22) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 22 results.

European Journal of Preventive Cardiology|May 19, 2021

Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectivenessSteven H J Hageman, Jannick A N Dorresteijn, Michiel L Bots, et al.

The American Journal of Medicine|February 15, 2026

Implications of 2023 ACR/EULAR Classification Criteria for antiphospholipid syndrome and current diagnostic and therapeutic insights: a Delphi consensusDrs B C Geertsema-Hoeve, Dr M C Stam-Slob, Dr M Bijl, et al.

Pageof 3